Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


04.03.2019

1 Am J Gastroenterol
3 Biochem Biophys Res Commun
1 BMC Cancer
2 BMC Gastroenterol
2 Dig Dis Sci
4 Eur Radiol
16 Hepatology
1 Indian J Gastroenterol
2 J Gastroenterol Hepatol
2 J Hepatol
1 J Pediatr
1 J Pediatr Surg
2 N Engl J Med
4 Oncogene
2 PLoS One
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. BAJAJ JS, Fagan A, White MB, Wade JB, et al
    Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
    Am J Gastroenterol. 2019 Jan 28. doi: 10.14309/ajg.0000000000000102.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. WANG X, Ma H, Wang X
    Nucleophosmin/B23 contributes to hepatic insulin resistance through the modulation of NF-kappaB pathway.
    Biochem Biophys Res Commun. 2019 Feb 21. pii: S0006-291X(19)30156.
    PubMed     Text format     Abstract available

  3. ZHANG H, Sun D, Wang G, Cui S, et al
    Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell.
    Biochem Biophys Res Commun. 2019 Feb 20. pii: S0006-291X(19)30258.
    PubMed     Text format     Abstract available

  4. JU C, Liu C, Yan S, Wang Y, et al
    Poly(ADP-ribose) Polymerase-1 is required for hepatocyte proliferation and liver regeneration in mice.
    Biochem Biophys Res Commun. 2019 Feb 26. pii: S0006-291X(19)30287.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. HE C, Zhang Y, Cai Z, Lin X, et al
    Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
    BMC Cancer. 2019;19:178.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  6. QI T, Zhu C, Lu G, Hao J, et al
    Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China: a retrospective study.
    BMC Gastroenterol. 2019;19:20.
    PubMed     Text format     Abstract available

  7. CHIU KW, Lin TL, Yong CC, Lin CC, et al
    Endoscopic injection sclerotherapy for pediatric bleeding esophageal varices complicated by gastric vein, main portal vein, splenic mesenteric junction, and splenic vein occlusion: a case report.
    BMC Gastroenterol. 2019;19:37.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Text format     Abstract available

  9. XIAO Y, Zhang S, Li Q, Liu Z, et al
    miR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05535.
    PubMed     Text format     Abstract available


    Eur Radiol

  10. RASSAM F, Zhang T, Cieslak KP, Lavini C, et al
    Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.
    Eur Radiol. 2019 Feb 22. pii: 10.1007/s00330-019-06029.
    PubMed     Text format     Abstract available

  11. LEE S, Kim SH, Hwang JA, Lee JE, et al
    Pre-operative ADC predicts early recurrence of HCC after curative resection.
    Eur Radiol. 2019;29:1003-1012.
    PubMed     Text format     Abstract available

  12. JHAVERI KS, Hosseini-Nik H, Sadoughi N, Janssen H, et al
    The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
    Eur Radiol. 2019;29:1039-1047.
    PubMed     Text format     Abstract available

  13. POETTER-LANG S, Staufer K, Baltzer P, Tamandl D, et al
    The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
    Eur Radiol. 2019;29:1048-1058.
    PubMed     Text format     Abstract available


    Hepatology

  14. HUELIN P, Sola E, Elia C, Sole C, et al
    Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis. A prospective study.
    Hepatology. 2019 Feb 27. doi: 10.1002/hep.30592.
    PubMed     Text format     Abstract available

  15. HARA K, Takeda A, Tsurugai Y, Saigusa Y, et al
    Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: a Propensity Score Analysis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30591.
    PubMed     Text format     Abstract available

  16. HARRISON SA, Rossi SJ, Paredes AH, Trotter JF, et al
    NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30590.
    PubMed     Text format     Abstract available

  17. WANG Y, Kory N, Cohen JC, Hobbs HH, et al
    PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30583.
    PubMed     Text format     Abstract available

  18. TODESCA P, Marzi L, Critelli RM, Cuffari B, et al
    Angiopoietin-2/Tie2 inhibition by regorafenib associates with striking response in a patient with aggressive hepatocellular carcinoma.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30588.
    PubMed     Text format     Abstract available

  19. RIMBAS RC, Rimbas M, Vinereanu D
    Echocardiographic Predictors of a Worse Outcome in Patients With Liver Cirrhosis: What Should We Assess?
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30584.
    PubMed     Text format     Abstract available

  20. WANG R, Zhu P
    Tuberculosis and anti-tuberculosis treatments cannot be ignored when evaluating cirrhotic patients co-infected with HIV or not.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30582.
    PubMed     Text format     Abstract available

  21. MOUSA O, Malhi H, Schwartz RE, Kulai TB, et al
    Hepatology Highlights.
    Hepatology. 2019;69:927-930.
    PubMed     Text format    

  22. HUANG Z, Wu LM, Zhang JL, Sabri A, et al
    DUSP12 Regulates Hepatic Lipid Metabolism through Inhibition of Lipogenesis and ASK1 Pathways.
    Hepatology. 2019 Mar 1. doi: 10.1002/hep.30597.
    PubMed     Text format     Abstract available

  23. CHEN JF, Lin BL
    Reply.
    Hepatology. 2018;68:1661.
    PubMed     Text format    

  24. YANG Y, Feng Y, Zhao X, Wang L, et al
    A New Concept: Pre-HCC Disease.
    Hepatology. 2018;68:1662.
    PubMed     Text format    

  25. PANDEY S
    Association of Nonalcoholic Fatty Liver Disease With Relative Skeletal Muscle Mass: A Public Health Perspective.
    Hepatology. 2018;68:1657.
    PubMed     Text format    

  26. RANDALL MH, Stoermann M, Rockey DC
    A "Faux" Case of Acute Liver Failure in a 28-Year-Old Pregnant Woman.
    Hepatology. 2018;68:1200-1202.
    PubMed     Text format    

  27. YANG E, Peng L, Lee WM
    Multiple admissions for acetaminophen overdose: Acetaminophen frequent fliers, a new entity?
    Hepatology. 2018;68:1197-1199.
    PubMed     Text format    

  28. CHAPIN CA, Burn T, Meijome T, Loomes KM, et al
    Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate.
    Hepatology. 2018;68:1087-1100.
    PubMed     Text format     Abstract available

  29. LAN T, Li C, Yang G, Sun Y, et al
    Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.
    Hepatology. 2018;68:1070-1086.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  30. SOOD V, Lal BB, Rastogi A, Khanna R, et al
    Regression of fibrosis in pediatric liver diseases.
    Indian J Gastroenterol. 2018;37:266-270.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  31. KUK N, Hodge A, Sun Y, Correia J, et al
    Human amnion epithelial cells and their soluble factors reduce liver fibrosis in a murine non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2019 Mar 1. doi: 10.1111/jgh.14643.
    PubMed     Text format     Abstract available

  32. TEOH NC
    Recent advances in the management of hepatocellular carcinoma: First, cut ... is the deepest or is it "no-touch" and exercise?
    J Gastroenterol Hepatol. 2019;34:481-482.
    PubMed     Text format    


    J Hepatol

  33. DEVARBHAVI H, Asrani SK, Kamath PS
    Reply to: "Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia".
    J Hepatol. 2019 Feb 19. pii: S0168-8278(19)30066.
    PubMed     Text format    

  34. HERNANDEZ-GEA V, Gottardi A, Leebeek FWG, Rautou PE, et al
    Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.
    J Hepatol. 2019 Feb 26. pii: S0168-8278(19)30130.
    PubMed     Text format     Abstract available


    J Pediatr

  35. FERNANDES DM, Pantangi V, Azam M, Salomao M, et al
    Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study.
    J Pediatr. 2018;200:174-180.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  36. FAHY AS, Shaikh F, Gerstle JT
    Multifocal hepatoblastoma: What is the risk of recurrent disease in the remnant liver?
    J Pediatr Surg. 2019 Feb 2. pii: S0022-3468(19)30073.
    PubMed     Text format     Abstract available


    N Engl J Med

  37. ROMEO S
    Notch and Nonalcoholic Fatty Liver and Fibrosis.
    N Engl J Med. 2019;380:681-683.
    PubMed     Text format    

  38. SARDH E, Harper P, Balwani M, Stein P, et al
    Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
    N Engl J Med. 2019;380:549-558.
    PubMed     Text format     Abstract available


    Oncogene

  39. DANG S, Zhou J, Chen Y, Chen P, et al
    Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0759.
    PubMed     Text format     Abstract available

  40. REEBYE V, Huang KW, Lin V, Jarvis S, et al
    Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
    Oncogene. 2018;37:3216-3228.
    PubMed     Text format     Abstract available

  41. JIANG Y, Xu E, Zhang J, Chen M, et al
    The Rbm38-p63 feedback loop is critical for tumor suppression and longevity.
    Oncogene. 2018;37:2863-2872.
    PubMed     Text format     Abstract available

  42. VANIOTIS G, Rayes RF, Qi S, Milette S, et al
    Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis.
    Oncogene. 2018;37:3790-3805.
    PubMed     Text format     Abstract available


    PLoS One

  43. WEGERMANN K, Henao R, Diehl AM, Murphy SK, et al
    Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLoS One. 2018;13:e0204308.
    PubMed     Text format     Abstract available

  44. ALKHOURI N, Johnson C, Adams L, Kitajima S, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
    PLoS One. 2018;13:e0202226.
    PubMed     Text format     Abstract available


    Transplantation

  45. GORGEN A, Rosales R, Sadler E, Beecroft R, et al
    Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002616.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: